These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35949467)

  • 21. Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria.
    Voorman A; Lyons H; Shuaib F; Adamu US; Korir C; Erbeto T; Bandyopadhyay AS; Okiror S
    J Infect Dis; 2024 Mar; 229(3):805-812. PubMed ID: 37357964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating vaccine derived polio virus type 2 outbreak and response in Yemen, 2021-2022, a retrospective descriptive analysis.
    Al-Qassimi MA; Al Amad M; Al-Dar A; Al Sakaf E; Al Hadad A; Raja'a YA
    BMC Infect Dis; 2024 Mar; 24(1):321. PubMed ID: 38491425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute flaccid paralysis surveillance performance from 2011 to 2020 in Jonglei State, South Sudan: progress and challenges encountered.
    Jil JM; Tegegne AA; Maleghemi S; Berta KK; Birru TG; Kilo OTD
    Pan Afr Med J; 2022; 42(Suppl 1):11. PubMed ID: 36158927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak response strategies with type 2-containing oral poliovirus vaccines.
    Kalkowska DA; Wassilak SGF; Pallansch MA; Burns CC; Wiesen E; Durry E; Badizadegan K; Thompson KM
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A142-A152. PubMed ID: 36402659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018.
    Mbaeyi C; Alleman MM; Ehrhardt D; Wiesen E; Burns CC; Liu H; Ewetola R; Seakamela L; Mdodo R; Ndoutabe M; Wenye PK; Riziki Y; Borus P; Kamugisha C; Wassilak SGF
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):225-230. PubMed ID: 30845121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polio outbreak response in Ethiopia.
    Mesfin G; Schluter W; Gebremariam A; Benti D; Bedada T; Beyene B; Yigzaw A; Taddess Z; Mbakuliyemo N; Babaniyi O
    East Afr Med J; 2008 May; 85(5):222-31. PubMed ID: 18814532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
    Molodecky NA; Jafari H; Safdar RM; Ahmed JA; Mahamud A; Bandyopadhyay AS; Shukla H; Quddus A; Zaffran M; Sutter RW; Grassly NC; Blake IM
    Vaccine; 2023 Apr; 41 Suppl 1():A93-A104. PubMed ID: 34629206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
    Harutyunyan V; Quddus A; Pallansch M; Zipursky S; Woods D; Ottosen A; Vertefeuille J; Lewis I
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A70-A78. PubMed ID: 35282924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Field investigation and response to a vaccine-derived poliovirus pre-tOPV switch in Southwest Nigeria, October 2015.
    Fatiregun A; Famiyesin E; Bawa S; Ogunbodede N
    Pan Afr Med J; 2020; 37():6. PubMed ID: 32983324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
    Voorman A; O'Reilly K; Lyons H; Goel AK; Touray K; Okiror S
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A105-A112. PubMed ID: 34483024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polio: The Disease that Reemerged after Six Years in Ethiopia.
    Tseha ST
    Ethiop J Health Sci; 2021 Jul; 31(4):897-902. PubMed ID: 34703190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress toward polio eradication--Somalia, 1998-2013.
    Mbaeyi C; Kamadjeu R; Mahamud A; Webeck J; Ehrhardt D; Mulugeta A
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S173-80. PubMed ID: 25316833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
    Alleman MM; Jorba J; Henderson E; Diop OM; Shaukat S; Traoré MA; Wiesen E; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1691-1699. PubMed ID: 34882653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strengthening acute flaccid paralysis surveillance post Ebola virus disease outbreak 2015 - 2017: the Liberia experience.
    Clarke A; Blidi N; Dahn B; Agbo C; Tuopileyi R; Rude MJ; Williams GS; Seid M; Gasasira A; Wambai Z; Skrip L; Nagbe T; Nyenswah T; Chukwudi JO; Johnson T; Talisuna A; Yahaya AA; Rajatonirina S; Fall IS
    Pan Afr Med J; 2019; 33(Suppl 2):2. PubMed ID: 31402963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.
    Etsano A; Damisa E; Shuaib F; Nganda GW; Enemaku O; Usman S; Adeniji A; Jorba J; Iber J; Ohuabunwo C; Nnadi C; Wiesen E
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):770-3. PubMed ID: 27490081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of oral polio vaccination against paralytic poliomyelitis: a matched case-control study in Somalia.
    Mahamud A; Kamadjeu R; Webeck J; Mbaeyi C; Baranyikwa MT; Birungi J; Nurbile Y; Ehrhardt D; Shukla H; Chatterjee A; Mulugeta A
    J Infect Dis; 2014 Nov; 210 Suppl 1():S187-93. PubMed ID: 25316835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019.
    Ameme DK; Yeboah YO; Odoom JK; Djokoto SK; Akyereko E; Mamudu A; Diwura M; Opare W; Avevor P; Diamenu S; Ohene SA; Kenu E; Asiedu-Bekoe F
    Arch Public Health; 2023 Jan; 81(1):1. PubMed ID: 36600260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.